Showing 1 - 10 of 276
Should the intellectual property rights on the first Covid-19 vaccines be temporarily lifted in applying the Trade-Related Aspect of Intellectual Property (TRIPS) flexibility? Is it right to grant the first generation of Covid-19 vaccines a special treatment from an IPR perspective? On what...
Persistent link: https://www.econbiz.de/10013197980
Persistent link: https://www.econbiz.de/10003839291
Persistent link: https://www.econbiz.de/10003839294
Persistent link: https://www.econbiz.de/10003805878
Persistent link: https://www.econbiz.de/10003929712
Persistent link: https://www.econbiz.de/10003875651
Persistent link: https://www.econbiz.de/10009696520
Persistent link: https://www.econbiz.de/10009718837
Persistent link: https://www.econbiz.de/10009718842
Persistent link: https://www.econbiz.de/10009718926